Glomerulonephritis
📧 Sign up to get email alerts when something new happens for Glomerulonephritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria [NA]
This clinical trial update describes efforts to optimize referral pathways for patients with hematuria and moderate-to-severe proteinuria, w…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Diagnosis System.
This update describes an ongoing clinical trial evaluating an AI-assisted renal biopsy diagnosis system. The study targets patients with chr…
-
EMA approval · 2025-12-08EMA Authorised: Filspari (sparsentan) — Vifor France
The European Medicines Agency has authorised Filspari (sparsentan) for glomerulonephritis, including IgA nephropathy, with orphan designatio…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy [Phase 2]
A Phase 2 clinical trial is planned to evaluate dapagliflozin for regulating immunological activity in membranous nephropathy; the study is …
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy. [Phase 4]
Clinical trial update for a multicenter Phase 4 study evaluating personalized therapy in patients with Immunoglobulin A Nephropathy, current…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis [Phase 2]
Phase 2 clinical trial evaluating finerenone in patients with non-diabetic glomerulonephritis; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland [Phase 2]
Phase 2 clinical trial evaluating daratumumab for monoclonal gammopathy of renal significance (MGRS) in Finland; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: TESTING -ON Post-Trial ObservatioNal Cohort Study
A post-trial observational cohort study named TESTING-ON, sponsored by The George Institute, is currently recruiting to observe outcomes in …
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE) [Phase 2]
Phase 2 results update reporting efficacy, safety and PK/PD of MOR202 in anti-PLA2R positive membranous nephropathy (NewPLACE).
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study
Pediatric nephrotic syndrome study aiming to identify biomarkers and outcome predictors through genetic, transcriptomic, and secretome multi…
-
CLINICAL_TRIALS trial_result · 2024-12-31Clinical Trial Update: ANTI-SARS-CoV-2 SEROCONVERSIO IN IMMUNE-MEDIATED KIDNEY DISEASES
A completed clinical trial update examining anti-SARS-CoV-2 seroconversion in patients with immune-mediated kidney diseases, including glome…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: KidneYou - Innovative Digital Therapy [NA]
Completed clinical trial update for KidneYou, an innovative digital therapy from Advice Pharma Group srl, investigating use in chronic kidne…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis [Phase 2]
A Phase 2 clinical trial evaluating KP104 for Glomerulonephritis to assess efficacy, safety, pharmacokinetics, and pharmacodynamics; the stu…
-
CLINICAL_TRIALS other · 2024-10-23Clinical Trial Update: Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency [Phase 1]
Phase 1 clinical trial of HRS-5965 in healthy subjects and individuals with renal impairment has completed.
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Using Renal Elastography Measurements for Evaluation of Glomerulonephritis Patients [NA]
A clinical trial at Assiut University is exploring renal shear wave elastography to evaluate biopsy-proven glomerulonephritis patients. The …
-
CLINICAL_TRIALS other · 2024-07-30Clinical Trial Update: Affection of Renal and Urinary System in IBD Patients
Clinical trial update for a study on kidney and urinary system issues in inflammatory bowel disease patients; recruitment has not started.
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3 [Phase 4]
This entry notes a Phase 4 clinical trial recruiting with Huaiqihuang Granule for primary glomerulonephritis in patients with chronic kidney…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Effect of Ramadan Fasting on Kidney Function and Proteinuria in Patients With Glomerulonephritis
A clinical trial studied the effect of Ramadan fasting on kidney function and proteinuria in patients with glomerulonephritis; the study has…
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of immunosuppressive therapy for IgA nephropathy in patients with stage 3 or 4 chronic kidn…
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted [Phase 2]
Phase 2 trial evaluating efficacy and safety of LNP023 in C3 glomerulopathy patients, including transplanted and non-transplanted cohorts, h…
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Empagliflozin in Patients With Glomerulonephritis [Phase 3]
Phase 3 trial update for empagliflozin in glomerulonephritis with proteinuria has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy [Phase 2, Phase 3]
Clinical trial update for plasma exchange in severe crescentic IgA nephropathy indicates termination after Phase 2/3.
-
CLINICAL_TRIALS trial_result · 2021-05-26Clinical Trial Update: Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 [Phase 1, Phase 2]
A Phase 1/Phase 2 trial investigating recovery of damaged cells to address post-COVID-19 sequelae and related conditions. Current status is …
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment [Phase 4]
Phase 4 trial updating prevention of recurrence after kidney transplantation in IgA nephropathy comparing ATG-F versus Basiliximab induction…
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis [Phase 4]
Clinical trial update for Jinshuibao in chronic kidney disease due to glomerulonephritis (Phase 4) assessing efficacy and safety.